Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial. (Record no. 27075764)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02733 a2200757 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517150542.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201808s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 2468-1253 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/S2468-1253(16)30189-3 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Bourlière, Marc |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20180813 |
| 245 00 - TITLE STATEMENT | |
| Title | Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | The lancet. Gastroenterology & hepatology |
| Date of publication, distribution, etc. | 03 2017 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 177-188 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adolescent |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antiviral Agents |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | DNA, Viral |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Administration Schedule |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hepatitis B Surface Antigens |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hepatitis B e Antigens |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hepatitis B virus |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hepatitis B, Chronic |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Interferon-alpha |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nucleosides |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nucleotides |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Patient Reported Outcome Measures |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Polyethylene Glycols |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Recombinant Proteins |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Young Adult |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rabiega, Pascaline |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ganne-Carrie, Nathalie |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Serfaty, Lawrence |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Marcellin, Patrick |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Barthe, Yoann |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Thabut, Dominique |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Guyader, Dominique |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hezode, Christophe |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Picon, Magali |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Causse, Xavier |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Leroy, Vincent |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bronowicki, Jean Pierre |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Carrieri, Patrizia |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Riachi, Ghassan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rosa, Isabelle |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Attali, Pierre |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Molina, Jean Michel |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bacq, Yannick |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tran, Albert |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Grangé, Jean Didier |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zoulim, Fabien |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fontaine, Hélène |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Alric, Laurent |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bertucci, Inga |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bouvier-Alias, Magali |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Carrat, Fabrice |
| 773 0# - HOST ITEM ENTRY | |
| Title | The lancet. Gastroenterology & hepatology |
| Related parts | vol. 2 |
| -- | no. 3 |
| -- | p. 177-188 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/S2468-1253(16)30189-3">https://doi.org/10.1016/S2468-1253(16)30189-3</a> |
| Public note | Available from publisher's website |
No items available.